 12-WEEK INTERVENTION: Subjects N110 will be randomized to the flavonoid supplement or placebo supplement groups for 12 weeks thus two independent groups run in parallel with 55 subjects. Supplements will be administered in a double-blinded manner, with the code held by Reoxcyn Discoveries Group until the end of the study. The goal is for N100 subjects to complete all phases of the study. Subjects will ingest two supplement supplements each day of the study, one before breakfast, and the second one before lunch. 